FDA approves Pfizer COVID-19 booster for 65 and older, others at high risk

After striking down widespread COVID-19 booster shots, the FDA OK'd Pfizer's third dose for people 65+ and those with specific health risks. Dr. Mike joins Good Day Philadelphia to discuss the decision.